×
Standard BioTools EBITDA 2010-2025 | LAB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Standard BioTools EBITDA 2010-2025 | LAB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$45.1B
Doximity (DOCS)
$11.3B
Hims & Hers Health (HIMS)
$10.7B
Tempus AI (TEM)
$9.8B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.7B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.9B
Phreesia (PHR)
$1.6B
10x Genomics (TXG)
$1.6B
Schrodinger (SDGR)
$1.5B
Azenta (AZTA)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Omnicell (OMCL)
$1.3B
Evolent Health (EVH)
$1.3B
Claritev (CTEV)
$761M
Fulgent Genetics (FLGT)
$587M
Veradigm (MDRX)
$547M
Butterfly Network (BFLY)
$448M
Talkspace (TALK)
$442M
Outset Medical (OM)
$344M
TruBridge (TBRG)
$331M
Health Catalyst (HCAT)
$271M
Nyxoah SA (NYXH)
$257M
SOPHiA GENETICS SA (SOPH)
$233M
KORU Medical Systems (KRMD)
$161M
Zepp Health (ZEPP)
$150M
American Well (AMWL)
$131M
EUDA Health Holdings (EUDA)
$123M